(NASDAQ: LNSR) Lensar's forecast annual revenue growth rate of 13.18% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.23%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.58%.
Lensar's revenue in 2026 is $60,264,000.On average, 5 Wall Street analysts forecast LNSR's revenue for 2026 to be $766,932,837, with the lowest LNSR revenue forecast at $734,449,010, and the highest LNSR revenue forecast at $794,649,748. On average, 5 Wall Street analysts forecast LNSR's revenue for 2027 to be $909,792,875, with the lowest LNSR revenue forecast at $818,730,044, and the highest LNSR revenue forecast at $1,029,432,628.
In 2028, LNSR is forecast to generate $1,173,582,682 in revenue, with the lowest revenue forecast at $1,023,412,555 and the highest revenue forecast at $1,319,747,618.